ONCOLYTICS BIOTECH INC

Nasdaq:ONCY

Pharmaceutical Preparations·CALGARY

Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies.

CEO

Kelly Jared

CFO

Look Kirk

News (8-K)

8 shown

Filed	Type	Description
3/20/26	Other	Material Modification to Rights of Security Holders	→
3/19/26	Other	Other Events	→
3/2/26	Other	Other Events	→
2/24/26	Other	Other Events	→
2/4/26	Other	Other Events	→
1/15/26	Vote	Submission of Matters to a Vote of Security Holders	→
↓

Prospectuses & Registrations

28 shown

Filed	Form	Description
12/9/25	424B3	424B3	→
12/5/25	F-4/A	F-4/A	→
10/20/25	F-4	F-4	→
10/17/25	424B5	424B5	→
8/22/25	F-3	F-3	→
7/25/24	F-10	F-10	→
↓

Filing History(1000 filings)

TypeDateAccessionPeriodSize

8-K

Mar 20, 2026

0001104659-26-032763FORM 8-K

Mar 17, 2026

764.1 KB

8-K

Mar 19, 2026

0001129928-26-0000118-K

Mar 19, 2026

176.0 KB

Mar 13, 2026

0001493152-26-0099834

Mar 11, 2026

4.5 KB

Mar 13, 2026

0001493152-26-0099824

Mar 12, 2026

4.4 KB

8-K

Mar 2, 2026

0001129928-26-0000098-K

Mar 2, 2026

159.9 KB

8-K

Feb 24, 2026

0001129928-26-0000068-K

Feb 24, 2026

167.8 KB

Feb 13, 2026

0001493152-26-006545

Feb 11, 2026

6.5 KB

Feb 13, 2026

0001493152-26-0065464

Feb 12, 2026

4.4 KB

Feb 13, 2026

0001493152-26-0065474

Feb 12, 2026

5.0 KB

Feb 13, 2026

0001493152-26-006544

Feb 12, 2026

4.4 KB

Feb 13, 2026

0001493152-26-0065424

Feb 12, 2026

5.0 KB

Feb 13, 2026

0001493152-26-0065434

Feb 12, 2026

4.4 KB

Feb 13, 2026

0001493152-26-0065484

Feb 11, 2026

6.0 KB

Feb 13, 2026

0001493152-26-0065414

Feb 11, 2026

5.0 KB

Feb 13, 2026

0001493152-26-006540

Feb 12, 2026

5.0 KB

8-K

Feb 4, 2026

0001129928-26-0000048-K

Feb 4, 2026

166.7 KB

Jan 20, 2026

0001493152-26-002879

Jan 16, 2026

5.0 KB

8-K

Jan 15, 2026

0001104659-26-004103FORM 8-K

Jan 15, 2026

220.2 KB

8-K

Jan 15, 2026

0001104659-26-003815FORM 8-K

Jan 14, 2026

214.3 KB

8-K

Jan 12, 2026

0001104659-26-002863FORM 8-K

Jan 8, 2026

241.0 KB

425

Jan 9, 2026

0001104659-26-002348FORM 425

—

1.2 MB

6-K

Jan 7, 2026

0001129928-26-0000026-K

Jan 7, 2026

36.8 KB

Jan 2, 2026

0001493152-26-0001393

Jan 1, 2026

24.7 KB

Jan 2, 2026

0001493152-26-0001413

Jan 1, 2026

19.6 KB

Jan 2, 2026

0001493152-26-000138

Jan 1, 2026

20.5 KB

25 filings shown

Filed	Form	Description
1/9/26	425	FORM 425	→
12/9/25	EFFECT	EFFECT	→
11/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
8/29/25	EFFECT	EFFECT	→
4/10/25	SUPPL	SUPPL	→
2/14/25	SCHEDULE 13G	SCHEDULE 13G	→
↓

ONCOLYTICS BIOTECH INC

News (8-K)

Prospectuses & Registrations

Filing History(1000 filings)

Ownership

Other Filings

Filed	Form	Description
3/13/26	4	4	→
3/13/26	4	4	→
2/13/26	4	4	→
2/13/26	4	4	→
2/13/26	4	4	→
2/13/26	4	4	→
↓